| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 17.77% | Oppenheimer | → $33 | Reiterates | Outperform → Outperform |
| 07/26/2023 | 10.64% | Goldman Sachs | $28 → $31 | Maintains | Buy |
| 07/26/2023 | 7.07% | Baird | $23 → $30 | Maintains | Neutral |
| 07/19/2023 | 10.64% | Stifel | $24 → $31 | Maintains | Buy |
| 07/13/2023 | 10.64% | Keybanc | $28 → $31 | Maintains | Overweight |
| 07/10/2023 | -0.07% | Goldman Sachs | $25 → $28 | Maintains | Buy |
| 06/29/2023 | 7.07% | Deutsche Bank | → $30 | Initiates Coverage On | → Buy |
| 06/09/2023 | 3.5% | Oppenheimer | $27 → $29 | Maintains | Outperform |
| 04/27/2023 | -3.64% | Oppenheimer | $28 → $27 | Maintains | Outperform |
| 04/17/2023 | -14.35% | Stifel | $27 → $24 | Maintains | Buy |
| 04/14/2023 | -10.78% | Goldman Sachs | $29 → $25 | Maintains | Buy |
| 02/08/2023 | -7.21% | Mizuho | → $26 | Maintains | Buy |
| 01/20/2023 | -10.78% | Stifel | $28 → $25 | Maintains | Buy |
| 01/18/2023 | -0.07% | Keybanc | $32 → $28 | Maintains | Overweight |
| 01/13/2023 | -7.21% | Mizuho | $31 → $26 | Maintains | Buy |
| 12/21/2022 | -0.07% | Oppenheimer | $30 → $28 | Maintains | Outperform |
| 12/20/2022 | -7.21% | Baird | $27 → $26 | Downgrades | Outperform → Neutral |
| 10/27/2022 | 10.64% | Mizuho | $34 → $31 | Maintains | Buy |
| 10/18/2022 | 21.34% | Mizuho | $36 → $34 | Maintains | Buy |
| 10/14/2022 | 14.2% | Keybanc | $34 → $32 | Maintains | Overweight |
| 10/11/2022 | 7.07% | Stifel | $32 → $30 | Maintains | Buy |
| 07/27/2022 | 21.34% | Keybanc | $36 → $34 | Maintains | Overweight |
| 07/12/2022 | 28.48% | Keybanc | $43 → $36 | Maintains | Overweight |
| 06/30/2022 | 21.34% | Stifel | → $34 | Initiates Coverage On | → Buy |
| 06/23/2022 | 14.2% | Goldman Sachs | $39 → $32 | Maintains | Buy |
| 06/02/2022 | 35.62% | Mizuho | $39 → $38 | Maintains | Buy |
| 04/28/2022 | 39.19% | Mizuho | $43 → $39 | Maintains | Buy |
| 02/15/2022 | 53.46% | Baird | $38 → $43 | Upgrades | Neutral → Outperform |
| 12/17/2021 | 53.46% | Mizuho | → $43 | Initiates Coverage On | → Buy |
| 12/02/2021 | 49.89% | Oppenheimer | $40 → $42 | Maintains | Outperform |
| 11/19/2021 | 53.46% | Keybanc | $40 → $43 | Maintains | Overweight |
| 10/15/2021 | 35.62% | Baird | $32 → $38 | Downgrades | Outperform → Neutral |
| 10/07/2021 | 35.62% | Oppenheimer | $68 → $38 | Maintains | Outperform |
What is the target price for Zurn Elkay Water (ZWS)?
The latest price target for Zurn Elkay Water (NYSE: ZWS) was reported by Oppenheimer on October 2, 2023. The analyst firm set a price target for $33.00 expecting ZWS to rise to within 12 months (a possible 17.77% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zurn Elkay Water (ZWS)?
The latest analyst rating for Zurn Elkay Water (NYSE: ZWS) was provided by Oppenheimer, and Zurn Elkay Water reiterated their outperform rating.
When is the next analyst rating going to be posted or updated for Zurn Elkay Water (ZWS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zurn Elkay Water, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zurn Elkay Water was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
Is the Analyst Rating Zurn Elkay Water (ZWS) correct?
While ratings are subjective and will change, the latest Zurn Elkay Water (ZWS) rating was a reiterated with a price target of $0.00 to $33.00. The current price Zurn Elkay Water (ZWS) is trading at is $28.02, which is within the analyst's predicted range.